Broadly Neutralising Antibodies: A New Frontier in HIV Treatment and Prevention
AI summaryBroadly neutralising antibodies (bNAbs) are a rare immune response in some people living with HIV, targeting stable parts of the virus. Recent trials show promise in prevention and treatment, though challenges remain. Researchers are exploring combination therapies and vaccines to harness bNAbs effectively.